ARVN · Arvinas Inc.
Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut.
5 SCIENCE PARK, NEW HAVEN, CT, UNITED STATES, 06511, New Haven, CT, 06511, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
471M
52 Wk Range
$6.74 - $14.51
Previous Close
$7.72
Open
$7.70
Volume
651,573
Day Range
$7.20 - $7.70
Enterprise Value
-3.464M
Cash
94.3M
Avg Qtr Burn
-48.3M
Insider Ownership
7.80%
Institutional Own.
84.10%
Qtr Updated
Jun 30th 2026